Vanberra Signal

OncoBox

Curated by Signal

Precision medicine tool for cancer and for study of age related diseases

Overview

OncoBox allows clinicians and researchers to select the best anti-cancer drug for their patients and to study age-related diseases. OncoFinder is its algorithm which allows users to analyze the gene expression data from microarray datasets by measuring the activation of intracellular signaling pathways. The algorithm maps the gene expression data onto known and custom intracellular signaling pathways and the difference in gene expression among signaling pathways can be used to predict which drugs and other interventions will be most effective for improving health. OncoBox Platform currently features more than 900 pathways in the Biochem Database, with pathways for intracellular cell signaling and metabolism in humans. It also features mouse signaling pathways. The database contains over 150 drugs. It can be used by clinicians to analyze drug effectiveness for cancer and can also be used by researchers to determine pathways involved in age-related diseases.

Key facts

Founded
2015

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Practice Management and electronic health records management solution

    Health TechnologyHutchinson, United States
  • Provider of an application for diabetes management

    Health TechnologyEureka, United States
  • Dental health-related information portal

    Health TechnologySunnyvale, United States

About OncoBox

What does OncoBox do?

OncoBox allows clinicians and researchers to select the best anti-cancer drug for their patients and to study age-related diseases.

Where is OncoBox headquartered?

OncoBox is headquartered in Los Angeles, United States.

When was OncoBox founded?

OncoBox was founded in 2015.

Which sector is OncoBox in?

OncoBox operates in Health Technology.

Who are OncoBox's competitors?

Companies similar to OncoBox include PDS Med, PRISM, and Ask the Dentist.